Ofatumumab - PDFSEARCH.IO - Document Search Engine

Ofatumumab
Results: 36

#	Item
11	Q&A GENMAB 4TH OF MARCH 2015 WITH JAN VAN DE WINKEL Q&A GENMAB 4TH OF MARCH 2015 Add to Reading List Source URL: www.proinvestor.com Language: English - Date: 2015-03-05 03:24:54 HuMax CD20 Winkel Pharmacology Biology Pharmaceutical industry Genmab Ofatumumab Monoclonal antibodies
12	If you cannot read this mail, click here. August 18, 2009 Amsterdam BioMed News Life Sciences Café - Sign up now! Add to Reading List Source URL: www.amsterdameconomicboard.com Language: English - Date: 2015-05-08 08:28:20 Ofatumumab Agilent Technologies Bruker BIOMED Science Park Amsterdam Framework Programmes for Research and Technological Development Varian Inc. Millipore Corporation Scientific instrument Genmab Technology Science and technology in Europe
13	idelalisib 100mg and 150mg tablets (Zydelig®) Gilead Sciences Ltd. SMC No[removed]February 2015 Add to Reading List Source URL: www.scottishmedicines.org.uk Language: English Oncology Bendamustine Ofatumumab Alemtuzumab Leukemia Rituximab Fludarabine Placebo Chemotherapy Medicine Lymphocytic leukemia B-cell chronic lymphocytic leukemia
14	JOHN C. BYRD, MD Office Address: Mailing Address: Office: Fax: Lab: Add to Reading List Source URL: osuwmcdigital.osu.edu Language: English - Date: 2014-05-01 10:48:22 Lymphocytic leukemia Hematologic neoplasms Ofatumumab Alemtuzumab Leukemia Hematological malignancy Pentostatin Bendamustine Targeted therapy Medicine Oncology B-cell chronic lymphocytic leukemia
15	pERC deliberated upon the cost effectiveness of ibrutinib compared with a treatment mix reflecting different local standards of care and noted there is currently no single standard of care in Canada in this clinical s Add to Reading List Source URL: www.pcodr.ca Language: English - Date: 2015-01-09 16:28:10 Lymphocytic leukemia Pharmacology B-cell chronic lymphocytic leukemia Orphan drugs Ofatumumab Leukemia Rituximab Mantle cell lymphoma End point of clinical trials Medicine Health Medical statistics
16	considerably higher than the manufacturer’s estimates. pERC agreed that the EGP’s re-analysis estimates were more reliable than those provided by the submitter and concluded that ofatumumab + chlorambucil is not co Add to Reading List Source URL: www.pcodr.ca Language: English - Date: 2014-12-04 16:10:34 Alkylating antineoplastic agents Nitrogen mustards Organochlorides Ofatumumab B-cell chronic lymphocytic leukemia Chlorambucil Fludarabine Leukemia Rituximab Chemistry Medicine Oncology
17	2143 Index a abatacept 936, 943, 949, 1087, 2027 Add to Reading List Source URL: www.wiley-vch.de Language: English - Date: 2014-12-22 21:03:20 Immune system Anatomy Immunology Biotechnology Glycoproteins Rituximab Ofatumumab Trifunctional antibody Humanized antibody Medicine Monoclonal antibodies Biology
18	Ottobre[removed]Elenchi dei prodotti medicinali per le malattie rare in Europa* Add to Reading List Source URL: www.orpha.net Language: English - Date: 2014-11-03 09:45:01 Orphan drugs Medicine Ofatumumab Orphanet Ponatinib Dasatinib Leukemia Hyperammonemia Carglumic acid Chemistry Organic chemistry Piperazines
19	Octobre[removed]Listes des médicaments pour les maladies rares en Europe* Add to Reading List Source URL: www.orpha.net Language: English - Date: 2014-11-03 09:45:01 Rare diseases Ofatumumab Carglumic acid Pulmonary hypertension Glycogen storage disease type II Orphanet Acute myeloid leukemia Leukemia Medicine Health Hepatology
20	ISF35 Active Immunotherapy for Blood Cancer NIH Protocol #[removed]Phase Ib Study of Autologous Ad-‐ISF35-‐Transduced CLL B Cells and Fludarabine, Cyclophosphamide, and Rituximab (FCR) in Subjects with Fludarabin Add to Reading List Source URL: osp.od.nih.gov Language: English - Date: 2013-12-31 14:02:52 T cells B-cell chronic lymphocytic leukemia Lymphocytic leukemia Hematologic neoplasms CD154 Leukemia Alemtuzumab Ofatumumab CD40 Medicine Immune system Oncology

UPDATE